Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been clinically diagnosed with narrowing at the start of a carotid artery (a major blood vessel in the neck) that is significant enough to require a nerve/brain-related procedure — specifically, narrowing greater than 50% in people who have had symptoms, or greater than 70% in people who have had no symptoms
- People aged 18 or older
- People who have detectable pulses in the arteries of both the upper arm and groin area
- People (or their authorised representative) who understand the purpose of the study and have signed a consent form agreeing to take part
Who may not be able to join:
- People who have narrowing or blockage affecting more than one blood vessel at the same time with symptoms
- People who are scheduled to have a procedure on more than one blood vessel at the same time
- People who have had an ischemic stroke (a stroke caused by a blocked blood vessel) within the past 2 weeks
- People who have any active bleeding, severe anaemia, or a blood-clotting disorder, including specific abnormal results in blood tests related to haemoglobin, platelet count, or clotting (confirm with trial site)
- People who have had a large stroke on the same side of the brain being treated, where lasting effects might make it hard to assess the study's outcomes
- People who have had a bleeding stroke (cerebral haemorrhage) in the past six months
- People who have any condition that might interfere with a specific type of imaging procedure called digital subtraction angiography, or that would make accessing an artery through the skin unsafe
- People who are currently participating in another clinical trial, whether in the active treatment or follow-up phase
- People who have a known allergy to iodine-based contrast dye, or who have reduced kidney function, as these are reasons the imaging procedure cannot safely be used
- People who are unable to understand or sign a consent form
- People who have severe damage to a major organ and whose treating doctor has assessed them as being at high risk from surgery or unlikely to tolerate a procedure
- People who score 2 or higher on a standard disability scale called the modified Rankin Scale, which measures how much a neurological condition affects daily life
- People whose life expectancy is estimated to be less than 6 months
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Sheng Liu, Professor, The First Affiliated Hospital with Nanjing Medical University
Phone: +8615895907771
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Successful rate of CAS
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.